Calculating a projected Net Present Value (NPV) for Geron (GERN) through 2033 using revenue and Price/Sales (P/S) multiples involves several analytical steps and relies heavily on specific assumptions. While Fintel provides robust data for such analyses, a full NPV calculation requires a financial model built with these inputs.
Here's how one might approach this, leveraging Fintel's data:
Key Components for NPV Calculation
-
Revenue Projections:
Fintel's forecast data for Geron Corporation (GERN) includes annual revenue estimates. For instance, the forecasted annual revenue for Geron Corporation in 2031-12-31 is 1,834 million USD. While Fintel provides projections up to 2031, extending these estimates to 2033 would require additional assumptions about growth rates for those subsequent years. Recent SEC filings indicate that Geron's product RYTELO® is generating revenue, with $39.4 million in Q1 2025 and $49.007 million in Q2 2025, and $76.5 million in product revenue since its commercial launch at the end of June 2024. These actual figures provide a base for assessing the reasonableness of long-term forecasts.
-
Price/Sales (P/S) Multiple:
To project a future market capitalization from revenue, an appropriate P/S multiple is needed. This multiple can be derived from Geron's historical P/S ratios, industry averages, or a forward-looking estimate based on the company's growth prospects and profitability. Fintel's "Metrics & Ratios" section for GERN would typically provide historical P/S data, which can inform the selection of a suitable multiple.
-
Discount Rate:
An NPV calculation requires a discount rate to bring future values back to their present worth. This rate typically reflects the company's cost of capital and the risk associated with its future cash flows.
Steps for a Projected NPV
To calculate the projected NPV, one would generally:
- Project Annual Revenue: Extend the available analyst revenue forecasts (e.g., up to 2031 from Fintel) to 2033 based on a chosen growth rate.
- Estimate Future Market Capitalization: Multiply the projected annual revenue for each year by a selected P/S multiple to arrive at a projected market capitalization for each year.
- Calculate Terminal Value: For the year 2033, a terminal value would typically be calculated, representing the value of the company beyond the explicit forecast period. This could also be based on a P/S multiple applied to 2033 revenue.
- Discount Future Values: Discount these projected market capitalizations and the terminal value back to the present using the chosen discount rate.
- Determine Per-Share Value: Divide the total present value by the current number of outstanding shares (e.g., 666,170,358 shares as of June 30, 2025) to get a per-share NPV.
It's crucial to note that long-term projections for a biopharmaceutical company like Geron, especially one with a recently launched product, carry significant uncertainty. The assumptions made for revenue growth, the P/S multiple, and the discount rate will profoundly impact the resulting NPV.
Fintel Resources for Further Research:
- Fintel's Forecast Page for GERN: Provides analyst revenue and earnings estimates.
- Fintel's Financials Section for GERN: Offers historical income statements, balance sheets, and cash flow statements, which can be used to derive historical P/S ratios and understand financial trends.
- SEC Filings: Review recent 10-K and 10-Q filings for management's outlook, product launch details, and R&D pipeline updates that could influence future revenue.
